CASP6 and polycystic ovary syndrome: Administration of SATE significantly decreased the levels of ovarian inflammatory biomarkers (TNF-α and NF-kB) and caspase-6 with an increase in HIF-1α level of PCOS + SATE group compared with untreated PCOS group (Fig. 3).